ArticleJournal of cellular and molecular medicine2025
Carbonic Anhydrase IX Induces Human Osteosarcoma Cell Metastasis by Activating HSPA6 Expression Through the AMPK Signalling Pathway.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Potential influence of carbonic anhydrase 9 genetic variants and expression levels on the progression of diabetic retinopathy.International journal of medical sciences · 2026Article
- Carbonic Anhydrase IX Induces Human Osteosarcoma Cell Metastasis by Activating HSPA6 Expression Through the AMPK Signalling Pathway.Journal of cellular and molecular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteosarcoma(OS), the most common primary bone cancer, has high metastatic potential and a high mortality rate. Carbonic anhydrase IX (CAIX), a hypoxia-induced transmembrane protein, is highly expressed in numerous cancers. Over the past decades, scientists have made extensive efforts to determine the role of CAIX in various cancers. However, the effects of CAIX on the metastasis of OS cell lines remain unclear. We examined the effectiveness of CAIX for inducing the invasion and migration of human OS cells and the underlying molecular mechanisms. We established CAIX-overexpressing human OS cells and found markedly increased migratory and invasive abilities in HOS and U2OS cell lines. In addition, CAIX overexpression increased the messenger ribonucleic acid (mRNA) and protein expression levels of heat shock protein family A member 6 (HSPA6) and the phosphorylation of adenosine-monophosphate-activated protein kinase (AMPK) signalling proteins. With HSPA6 knockdown, U2OS cells exhibited significantly reduced migratory and invasive abilities. Moreover, treatment with an AMPK inhibitor (dorsomorphin) suppressed CAIX-induced HSPA6 expression and the metastasis of U2OS cells. In conclusion, the results indicate that CAIX overexpression mediates HSPA6 expression through the AMPK signalling pathway, which consequently induces the metastasis of OS cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.